Actual 5-year survival rates after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for patients with peritoneal carcinomatosis (PC) of colorectal origin were reported in this study. A total of 103 patients were analyzed, with a median follow-up of survivors at 88 months. The 5-year overall survival (OS) was 36%, and the median OS was 42.5 months. Factors associated with poor survival included high peritoneal cancer index (PCI) and incomplete CRS. However, patients with low PCI who underwent complete surgical resection achieved favorable long-term survival with a 5-year OS of 60.7%.
Journal Article by Sarfaty E, Khajoueinejad N (…) Cohen NA et 5 al. in Ann Surg Oncol
© 2023. Society of Surgical Oncology.